FIELD: medicine.
SUBSTANCE: method is realised in the following way: the level of brain-derived neurotrophic factor - BDNF is determined in blood serum of patients with type 2 diabetes mellitus, and if BDNF level is from 500 to 1000 pg/ml, moderate cognitive disorders are diagnosed, if BDNF level is from 1000 to 1700 pg/ml, light cognitive disorders are diagnosed, if BDNF level is higher than 1700 pg/ml, cognitive disorders are absent. The invention provides early diagnostics of cognitive disorders in patients with type 2 diabetes mellitus.
EFFECT: method is self-descriptive, accurate, objective, meets modern requirements to methods of laboratory diagnostics and can be recommended for application in clinical practice.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRECLINICAL DIAGNOSIS OF COGNITIVE IMPAIRMENT IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2021 |
|
RU2772714C1 |
| DIAGNOSTIC TECHNIQUE FOR COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITH ASSESSMENT OF CEREBRAL BLOOD FLOW | 2020 |
|
RU2741220C1 |
| DIAGNOSTIC TECHNIQUE FOR COGNITIVE DYSFUNCTION IN PATIENTS WITH TYPE 1 DIABETES MELLITUS BY PROTON MAGNETIC RESONANCE SPECTROSCOPY | 2018 |
|
RU2705911C1 |
| METHOD FOR RECOVERY OF COGNITIVE FUNCTIONS IN CEREBROVASCULAR PATHOLOGY | 2015 |
|
RU2586312C1 |
| METHOD OF EARLY DIAGNOSIS OF COGNITIVE IMPAIRMENTS IN YOUNG AND MIDDLE-AGED PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH MINIMAL NEUROLOGICAL SYMPTOMS | 2021 |
|
RU2790236C1 |
| METHOD FOR PREDICTING PROGRESSION OF VASCULAR MODERATE COGNITIVE IMPAIRMENT | 2023 |
|
RU2816620C1 |
| METHOD FOR DIAGNOSING INSULIN RESISTANCE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2024 |
|
RU2825046C1 |
| METHOD OF DIAGNOSTICS OF SUBCLINICAL STAGE OF DIABETIC NEUROPATHY | 2018 |
|
RU2671630C1 |
| METHOD FOR IDENTIFYING A GROUP OF PEOPLE WITH AN INCREASED RISK OF DEVELOPING ALZHEIMER'S DISEASE | 2021 |
|
RU2781612C1 |
| METHOD OF PREDICTING RISK OF DEVELOPING DIABETIC DISTAL POLYNEUROPATHY IN RESIDENTS OF CENTRAL RUSSIA WITH TYPE 2 DIABETES MELLITUS BASED ON GENOTYPING OF rs1043618 POLYMORPHISM OF HSPA1A GENE | 2023 |
|
RU2809905C1 |
